Latest updates for Bimeda
Fresh curated links around Bimeda are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to
- Protecting welfare, productivity and performance in flocks this autumn
- Miebo 20$ otc Europe and 750$ WAC U.S.A.
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Protecting welfare, productivity and performance in flocks this autumn
As autumn approaches, many of us are reviewing flock health plans and considering how best to protect sheep from external parasites to enhance productivity and welfare. The Irish g...
Miebo 20$ otc Europe and 750$ WAC U.S.A.
Miebo 20$ otc Europe and 750$ WAC U.S.A. Anonymous (not verified) Sat, 08/29/2026 - 09:42 field_thread_url https://cafepharma.com/boards/threads/miebo-20-o...
<![CDATA[M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration wit...
<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>
Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies
Eli Lilly has struck a deal to acquire Merida Biosciences for up to $2.875 billion, establishing a beachhead in efforts to treat disease through the selective degradation of pathog...
Lilly Looks Beyond Obesity with Up-to-$2.9B Acquisition of Merida Biosciences
Based in Cambridge, MA, Merida develops biologic drugs that are engineered to selectively degrade pathogenic autoantibodies linked to a number of immune-mediated conditions. Merida...
<![CDATA[Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics for alvelestat ]]>
The first cattle vaccine for Theileria is now available to help producers combat a deadly tick-borne disease
The first-ever cattle vaccine to address Theileria is now available. Dr. Alan Young, the founder and Chief Technology Officer for Medgene, says it is administered in two doses. “...
<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.